Aerin Medical today touted one-year results from a trial evaluating the safety and efficacy of its RhinAer system in those with chronic rhinitis. Sunnyvale, Calif.–based Aerin designed RhinAer as a temperature-controlled radiofrequency technology used to disrupt nerve signals that cause chronic rhinitis symptoms. According to a news release, the study demonstrated that, following a single […]
Aerin Medical
Aerin Medical touts study of nasal airway obstruction treatment
Aerin Medical today touted results from a three-month study of its VivAer treatment for nasal airway obstruction (NAO). Sunnyvale, Calif.-based Aerin’s VivAer was studied in the VATRAC trial, with results published by the International Forum of Allergy and Rhinology. According to a news release, the study confirmed the safety and efficacy of VivAer in treating […]
DTW Podcast: KCK’s Long says deals getting done during COVID era
In this week’s DeviceTalks Weekly Podcast, Karen Long, managing director at KCK Group, says startups looking for funding have an opportunity to catch the eye and ear of investors. KCK, an active medtech investor, has been involved in two sizable investments this summer including Aerin Medical and NeuroPace. Both were portfolio companies, but Long says […]
Aerin Medical closes $48M financing, appoints new CEO
Aerin Medical announced today that it closed a $48 million equity financing and appointed Matt Brokaw as its new president & CEO. Brokaw previously served in roles at Tusker Medical, Spirox, Entellus Medical, Stryker (NYSE:SYK), Acclarent, Johnson & Johnson (NYSE:JNJ) and Smith & Nephew (NYSE:SNN). “Aerin is primed for its next phase of growth, propelled by non-invasive treatments […]
20 medical device startups you need to know
The medtech industry isn’t immune from COVID-19 troubles, but exciting innovation continues. These 20 medical device startups have grabbed our attention. Tom Salemi, DeviceTalks Editorial Director and Sean Whooley, Assistant Editor A number of medical device startups continue to make waves across the space, with new technologies and eye-watering fundraising rounds highlighting some exciting prospects. […]
Aerin Medical wins FDA clearance for nonsurgical chronic rhinitis procedure
Aerin Medical announced today that it won FDA clearance for its RhinAer Stylus for nonsurgical treatment of chronic rhinitis. RhinAer Stylus is designed to directly disrupt the signals that cause symptoms of nonallergic rhinitis through Aerin’s proprietary temperature-controlled technology that goes through the nasal airway to provide a therapeutic effect while minimizing risk to surrounding […]
Aerin Medical closes $16.7m Series C
Nasal airflow device developer Aerin Medical said today it closed a $16.7 million Series C financing round which it operated in 2 separate stages. The company said an initial closing of $6.1 million was led by the Targeted Technology fund, with a 2nd closing of $10.6 million led by the KCK group. As part of the financing […]
Update: Aerin Medical raises $6.7m for nasal RF device
Nasal airflow device developer Aerin Medical raised $6.7 million in a new round of equity financing, according to an SEC filing posted last week, and CEO Fred Dinger spoke to MassDevice.com about the company’s trajectory and what the funding is slated for. Aerin Medical is developing a novel nasal breathing repair device for treating nasal […]
